Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$0.12 - $0.19 $60 - $95
-500 Reduced 14.29%
3,000 $0
Q4 2023

Apr 12, 2024

SELL
$0.15 - $0.22 $4,800 - $7,040
-32,000 Reduced 90.14%
3,500 $0
Q4 2022

Feb 09, 2023

SELL
$0.16 - $0.25 $8,720 - $13,625
-54,500 Reduced 60.56%
35,500 $5,000
Q3 2022

Nov 02, 2022

SELL
$0.2 - $0.38 $7,000 - $13,300
-35,000 Reduced 28.0%
90,000 $19,000
Q2 2022

Aug 04, 2022

BUY
$0.2 - $0.34 $4,000 - $6,800
20,000 Added 19.05%
125,000 $27,000
Q4 2021

Feb 14, 2022

SELL
$0.31 - $0.58 $37,200 - $69,600
-120,000 Reduced 53.33%
105,000 $32,000
Q3 2021

Oct 26, 2021

BUY
$0.46 - $0.81 $97,290 - $171,315
211,500 Added 1566.67%
225,000 $118,000
Q2 2021

Jul 14, 2021

BUY
$0.72 - $1.46 $9,720 - $19,710
13,500 New
13,500 $11,000

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $127M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Game Plan Financial Advisors, LLC Portfolio

Follow Game Plan Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Game Plan Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Game Plan Financial Advisors, LLC with notifications on news.